Yahoo
HKSE - Delayed Quote HKD

China Shineway Pharmaceutical Group Limited (2877.HK)

7.510 +0.090 (+1.21%)
As of 1:26:17 PM GMT+8. Market Open.
View in AlphaSpace Currency in CNY All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
2,663,804
3,135,419
3,778,043
4,516,538
3,950,636
Cost of Revenue
765,588
869,212
946,294
1,122,419
1,012,322
Gross Profit
1,898,216
2,266,207
2,831,749
3,394,119
2,938,314
Operating Expense
1,239,818
1,548,405
1,989,147
2,418,584
2,215,910
Operating Income
658,398
717,802
842,602
975,535
722,404
Net Non Operating Interest Income Expense
196,577
210,675
170,589
92,470
91,801
Pretax Income
1,062,897
1,269,266
1,145,721
1,240,253
917,025
Tax Provision
258,454
319,318
305,669
270,743
194,252
Net Income Common Stockholders
804,443
949,948
840,052
969,510
722,773
Diluted NI Available to Com Stockholders
804,443
949,948
840,052
969,510
722,773
Basic EPS
1.07
1.26
1.11
1.28
0.96
Diluted EPS
1.07
1.26
1.11
1.28
0.96
Basic Average Shares
755,400
755,400
755,400
755,400
755,400
Diluted Average Shares
755,400
755,400
755,400
755,400
755,400
Total Expenses
2,005,406
2,417,617
2,935,441
3,541,003
3,228,232
Net Income from Continuing & Discontinued Operation
804,443
949,948
840,052
969,510
722,773
Normalized Income
825,334.812
976,692.900
844,899.972
973,764.080
729,729.464
Interest Income
198,609
216,360
176,718
95,207
92,431
Interest Expense
2,032
5,685
6,129
2,737
630
Net Interest Income
196,577
210,675
170,589
92,470
91,801
EBIT
1,064,929
1,274,951
1,151,850
1,242,990
917,655
EBITDA
1,064,929
1,345,835
1,220,585
1,303,223
1,103,517
Reconciled Cost of Revenue
765,588
869,212
946,294
1,122,419
1,012,322
Reconciled Depreciation
--
70,884
68,735
60,233
185,862
Net Income from Continuing Operation Net Minority Interest
804,443
949,948
840,052
969,510
722,773
Total Unusual Items Excluding Goodwill
-27,604
-35,735
-6,612
-5,440
-8,828
Total Unusual Items
-27,604
-35,735
-6,612
-5,440
-8,828
Normalized EBITDA
1,092,533
1,381,570
1,227,197
1,308,663
1,112,345
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-6,712.188
-8,990.100
-1,764.028
-1,185.920
-1,871.536
12/31/2022 - 12/2/2004

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: